PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'UOSD Terapia Intensiva Post-Operatoria, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy.\', \'Intensive Care Unit, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy.\', \'Dipartimento di Microbiologia e Virologia, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy.\', \'Central Pharmacy, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy.\', \'UOC Laboratorio Analisi, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy.\', \'Hematology Unit, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2020.01942
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 32983123
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Case Report: Canakinumab for the Treatment of a Patient With COVID-19 Acute Respiratory Distress Syndrome.
?:type

Metadata

Anon_0  
expand all